组织扩张器乳房再造术后引流时间延长的预测因素
本研究回顾了1056例延迟-即刻两阶段组织扩张器乳房再造病例,中位引流时间为10天,24.2%的病例引流超过12天被定义为引流时间延长。多因素分析显示高龄、高BMI、新辅助化疗、置入大型Siltex毛面扩张器及初始注水量较大是引流时间延长的独立危险因素。脱细胞真皮基质的作用因乳房大小而异,在切除标本重量大于400g时具有保护作用,而在小于等于400g时则是显著预测因素。
要点
- 高龄、高BMI、新辅助化疗、大型毛面扩张器和初始注水量大是引流延长的独立危险因素。
- 脱细胞真皮基质对引流的影响因乳房大小而异:标本>400g时保护,≤400g时延长引流。
- 扩张器大小、纹理和初始注水量对引流的影响不受乳房切除标本重量影响。
核心结论
- 多种因素包括重建手术相关因素可能影响组织扩张器乳房再造术后的引流时间。
研究设计与样本
- 回顾性分析2013年1月至2017年7月间接受延迟-即刻两阶段组织扩张器乳房再造的1056例(1002例患者)病例。
- 引流时间延长定义为超过整个队列引流时间第75百分位数。
主要发现
- 中位引流时间为10天,256例(24.2%)引流超过术后12天,归类为引流时间延长。
- 多因素分析显示高龄、高BMI、新辅助化疗、置入大型Siltex毛面组织扩张器及初始注水量较大是引流时间延长的独立危险因素。
- 扩张器的大小、纹理和初始注水量对引流时间的影响不受乳房切除标本重量的影响。
- 脱细胞真皮基质的使用根据乳房大小产生矛盾效应:在乳房切除标本重量大于400g的病例中具有保护作用,而在小于等于400g的病例中是显著的预测因素。
关键数值与推荐
- 引流时间延长定义为引流时间超过整个队列的第75百分位数(本队列中为术后12天)。
临床怎么用
- 对于具有高龄、高BMI、新辅助化疗、使用大型毛面扩张器或初始注水量大的患者,应预期引流时间可能延长并加强管理。
- 在乳房切除标本重量≤400g时使用脱细胞真皮基质可能增加引流时间延长的风险,需权衡利弊。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A closed-suction drain is usually inserted during tissue expander-based breast reconstruction. Prolonged duration of drain retention can disturb patients' daily lives and affect overall sociomedical costs. This study aimed to investigate factors that may influence the drainage and to identify predictors of unusually prolonged drain duration. METHODS: Patients who underwent delayed-immediate, two-stage breast reconstruction using a tissue expander between January of 2013 and July of 2017 were reviewed. Prolonged drain duration was defined as drain duration for longer than the 75th percentile of that for the entire cohort. Effects of patient- and operation-related variables on drainage and prolonged drain duration were evaluated. RESULTS: A total of 1056 cases (1002 patients) were analyzed. The median drain duration was 10 days. Drain placement for more than 12 postoperative days was observed in 256 cases (24.2 percent), classified as prolonged drain duration. Multivariate analyses demonstrated that old age, high body mass index, neoadjuvant chemotherapy, insertion of large Siltex textured tissue expanders, and greater volume of initial inflation were independent risk factors of prolonged drain duration. The size and texture of the tissue expanders and initial inflation volume retained their influence, regardless of mastectomy specimen weight. Use of acellular dermal matrix had contradictory effects according to breast size, being protective against prolonged drain duration in cases with mastectomy specimen weight greater than 400 g, and being a significant predictor for it in cases with mastectomy specimen weight less than or equal to 400 g. CONCLUSION: Several factors, including reconstructive operation-related factors, might influence drain duration following tissue expander-based breast reconstruction. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, III.
引用
- Lee KT, Hong SH, Jeon BJ, et al. Predictors for Prolonged Drainage following Tissue Expander-Based Breast Reconstruction. Plast Reconstr Surg. 2019. PMID: 31246795. doi:10.1097/PRS.0000000000005697
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。